3631 results for «310»

Filter By

3631 results

Complex and challenging cases I

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!

Complex and challenging cases I

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice

Complex and challenging cases II

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!

Complex and challenging cases II

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

Novel approach in the management of severely calcified lesions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.

Novel approach in the management of severely calcified lesions

PCI optimisation: OCT and physiology in a complex multivessel disease case

18 Dec 2019 – From GulfPCR-GIM 2019

The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).

The key objectives of this case are:

  1. Utility of FFR in physiological assessment of a...
PCI optimisation: OCT and physiology in a complex multivessel disease case

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

All you need to know to start optimising outcomes in PCI: OCT and physiology

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...

All you need to know to start optimising outcomes in PCI: OCT and physiology

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

Improving patient access and clinical outcomes for valvular heart disease

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.

Improving patient access and clinical outcomes for valvular heart disease

Interactive Case Corner 1 - Thrombosed AVG, bifurcation lesions & diffuse CAD

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of challenging clinical cases, such as myocardial revascularisation in diffuse CAD, PCI of bifurcation lesion with DK crush technique, angioplasty of totally thrombosed arteriovenous graft, and more!

Interactive Case Corner 1 - Thrombosed AVG, bifurcation lesions & diffuse CAD

Interactive Case Corner 2 - Rasmussen's aneurysm, recurrent haemoptysis & acute limb ischemia

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of challenging and complex clinical cases, such as rotational atherectomy with distal left radial approach, endovascular management of Rasmussen's aneurysm, recurrent haemoptysis caused by a large pulmonary artery aneurysm, and more!

Interactive Case Corner 2 - Rasmussen's aneurysm, recurrent haemoptysis & acute limb ischemia

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI
Didn’t find what you were looking for?